Article
Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play.
Pathology - 1 Mar 2024
Satgunaseelan Laveniya, Sy Joanne, Shivalingam Brindha, Sim Hao-Wen, Alexander Kimberley L, Buckland Michael E
Abstract excerpt
Central nervous system (CNS) tumours were one of the first cancer types to adopt and integrate molecular profiling into routine clinical diagnosis in 2016. The vast majority of these biomarkers, used to discriminate between tumour types, also offered prognostic information. With the advent of The Cancer Genome Atlas (TCGA) and other large genomic datasets, further prognostic sub-stratification was possible within...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
